NASDAQ: PRQRProqr Therapeutics Nv Stock Ownership - Who owns Proqr Therapeutics Nv?
Insider buying vs selling
Have Proqr Therapeutics Nv insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PRQR insiders and whales buy or sell their stock.
PRQR Shareholders
What type of owners hold Proqr Therapeutics Nv stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Adage Capital Partners GP LLC | 6.13% | 6,601,938 | $17.50M | Institution |
| Privium Fund Management Bv | 4.64% | 4,997,562 | $13.24M | Institution |
| Affinity Asset Advisors LLC | 3.25% | 3,499,512 | $9.27M | Institution |
| Morgan Stanley | 2.86% | 3,083,490 | $8.17M | Institution |
| Sio Capital Management LLC | 1.93% | 2,075,139 | $5.50M | Institution |
| Aberdeen Group PLC | 1.72% | 1,850,348 | $4.90M | Institution |
| Kynam Capital Management LP | 1.53% | 1,649,462 | $4.37M | Institution |
| Dafna Capital Management LLC | 1.46% | 1,567,561 | $4.15M | Institution |
| Siren LLC | 1.44% | 1,552,183 | $4.11M | Institution |
| Woodline Partners LP | 1.40% | 1,504,000 | $3.99M | Institution |
PRQR vs Biotech Stocks
Proqr Therapeutics Nv Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.